Most of the emphasis on myotonic dystrophy has been on DM1 or Myotonic Dystrophy Type 1 Now a new generous gift will push the reseach front on DM2! A great day!
Gift Will Advance Research on Myotonic Dystrophy Type 2
September 09, 2014
Albert (Alfy) and Lilyan (Lil) Nathan
A $1.25 million gift from Lilyan (Lil) and Albert (Alfy) Nathan of Florida and Michael and Sherry Goldberg of Chicago will create a new center dedicated to research on myotonic dystrophy type 2 (DM2) at the University of Rochester School of Medicine and Dentistry. The gift will be used to support a new research program that will be led by UR Medicine neurologist Chad Heatwole, M.D.
This tremendously complex disease that is myotonic dystrophy may be narrowing for a cure in the next few years. The root cause is known. There are a number of models or ways that the disease can be fixed. One approach that of an antisense nucleotide has been tried on a mouse that had myotonic dystrophy and it worked. (Isis pharmaceuticals). Tomorrow at the meeting below Dr. Richard Moxley one of the foremost researchers into myotonic dystrophy will be speaking about “Curing Myotonic Dystrophy”. It’s a step in the right direction and an indication that there might possibly be a cure coming in the future…
2012 MSG Scientific Annual Meeting
Clinical Trial Design and Biomarkers in Neuromuscular Disease
Beaver Hollow Conference Center, Java Center, NY September 27 – 29, 2012
8:30 PM Keynote Speaker: Richard Moxley (University of Rochester)
Curing Myotonic Dystrophy
To anyone affected with this disease, Hope is there and perhaps not too far out!